Aldevron is a leading Contract Development and Manufacturing Organisation (CDMO) with over 25 years of experience in delivering custom-manufactured and off-the-shelf solutions for cell and gene therapy development. The company accelerates the path from small-scale, pre-clinical and early-phase development through to late-stage clinical trials and commercial supply by providing plasmid DNA, RNA, and protein at phase-appropriate quality and scale. Aldevron also offers expertise to support clients through process development, assay development and analytics, as well as regulatory support. The Company's mission is to be the engine of innovation for genomic medicine pioneers striving to revolutionise global health.

Services include:
- Cell and Gene Therapy
- Regulatory Services
- Protein and Peptide
- Analytical Services
- Containment

Aldevron stands out as a crucial player in the pharmaceutical industry, providing vital support to clients throughout the development process. For more information, visit aldevron.com.